PCPP (poly[di(carboxylatophenoxy)-phosphazene]) microparticles co-encapsulating ovalbumin and CpG oligo-deoxynucleotides are potent enhancers of antigen specific Th1 immune responses in mice

Vaccine. 2010 Dec 6;28(52):8306-14. doi: 10.1016/j.vaccine.2010.09.080. Epub 2010 Oct 29.

Abstract

We generated poly[di(carboxylatophenoxy)-phosphazene] (PCPP) microparticles encapsulating ovalbumin (OVA) and CpG of 0.5-2.5 μm in diameter with an encapsulation efficiency of approximately 63% and 95% respectively. In mice the microparticles generated high antigen-specific IgG, IgG1 and IgG2a titers with higher IgG2a/IgG1 ratios. Whole body in vivo imaging of mice subcutaneously injected with MPs showed several fold increase of OVA and CpG in draining inguinal lymph nodes compared to soluble formulations. We conclude that PCPP MPs are more effective in enhancing immune responses compared to soluble formulations, due to co-delivery of OVA and CpG resulting in a Th1 type of immune response.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adjuvants, Immunologic / administration & dosage*
  • Animals
  • Drug Carriers*
  • Immunoglobulin G / blood
  • Injections, Subcutaneous
  • Lymph Nodes / immunology
  • Mice
  • Mice, Inbred BALB C
  • Microspheres*
  • Oligodeoxyribonucleotides / administration & dosage*
  • Organophosphorus Compounds / administration & dosage*
  • Ovalbumin / immunology*
  • Polymers / administration & dosage*
  • Th1 Cells / immunology*
  • Whole Body Imaging / methods

Substances

  • Adjuvants, Immunologic
  • CPG-oligonucleotide
  • Drug Carriers
  • Immunoglobulin G
  • Oligodeoxyribonucleotides
  • Organophosphorus Compounds
  • Polymers
  • poly(di(carboxylatophenoxy)phosphazene)
  • Ovalbumin